rapid
identif
exist
emerg
respiratori
virus
crucial
combat
outbreak
epidem
matrixassist
laser
desorptionion
timeofflight
mass
spectrometri
malditof
ms
rapid
reliabl
identif
method
bacteri
diagnost
use
virolog
diagnost
mass
spectrometri
system
investig
identif
respiratori
virus
howev
sampl
prepar
method
labori
timeconsum
studi
reliabl
rapid
sampl
prepar
method
develop
allow
identif
cultur
respiratori
virus
tenfold
serial
dilut
ten
cultur
influenza
strain
mix
sampl
influenza
viru
human
metapneumoviru
respiratori
syncyti
viru
reconstitut
clinic
sampl
treat
develop
sampl
prepar
method
subsequ
peptid
subject
malditof
ms
liquid
chromatographi
tandem
mass
spectrometri
lcmsm
influenza
strain
identifi
subtyp
level
within
h
malditof
ms
h
lcmsm
exclud
cultur
time
sensit
lcmsm
higher
compar
malditof
ms
addit
lcmsm
abl
discrimin
two
virus
mix
sampl
abl
identifi
viru
reconstitut
clinic
sampl
develop
improv
rapid
sampl
prepar
method
allow
gener
rapid
identif
cultur
respiratori
virus
mass
spectrometri
respiratori
virus
major
caus
infect
natur
outbreak
epidem
approxim
million
case
viral
communityacquir
pneumonia
occur
everi
year
million
children
million
adult
ruuskanen
et
al
wide
rang
virus
includ
current
circul
subtyp
influenza
viru
influenza
influenza
influenza
b
viru
respiratori
syncyti
viru
rsv
parainfluenza
virus
adenoviru
rhinoviru
implic
respiratori
tract
infect
past
decad
last
ten
year
new
virus
emerg
sever
acut
respiratori
syndrom
sar
viru
middl
east
respiratori
syndrom
mer
avian
influenza
viru
human
metapneumoviru
hmpv
coronavirus
human
bocaviru
rapid
identif
exist
emerg
respiratori
virus
utmost
import
combat
outbreak
epidem
start
earli
therapi
prophylaxi
current
cell
cultur
serolog
realtim
revers
transcriptionpolymeras
chain
reaction
rrtpcr
use
virolog
diagnost
howev
drawback
techniqu
serolog
rrtpcrbase
assay
target
direct
thu
potenti
miss
nonselect
emerg
pathogen
virus
binnick
et
al
yang
et
al
ii
cultur
time
consum
iii
serologybas
assay
applic
acut
phase
andor
low
sensit
furthermor
multipl
test
need
detect
subtyp
mix
infect
matrixassist
laser
desorptionionizationtim
flight
mass
spectrometri
malditof
ms
gener
techniqu
rapidli
identifi
cultur
microorgan
seng
et
al
van
veen
et
al
analysi
bacteria
mass
spectrometri
ms
made
great
progress
last
two
decad
http
author
publish
elsevi
bv
open
access
articl
cc
byncnd
licens
http
employ
mani
hospit
rapid
reliabl
altern
tradit
identif
method
thu
far
mass
spectrometrybas
method
use
virolog
diagnost
howev
shown
purifi
influenza
viru
particl
could
identifi
either
malditof
ms
maldi
fourier
transform
ion
cyclotron
reson
ms
maldifticr
ms
identif
base
proteolyt
digest
concentr
purifi
viral
sampl
mass
spectrometri
analysi
specif
peptid
mass
profil
sampl
prepar
method
use
studi
includ
viru
concentr
andor
purif
either
ultracentrifug
differenti
centrifug
precipit
filtrat
isol
viral
particl
protein
affin
captur
immunoassay
gel
electrophoresi
downard
et
al
schwahn
et
al
schwahn
et
al
b
chou
et
al
jang
et
al
nguyen
downard
fernand
downard
sampl
prepar
procedur
labori
often
time
consum
h
therefor
applic
highthroughput
virolog
diagnost
aim
studi
develop
rapid
gener
robust
sampl
prepar
method
malditof
ms
lcmsm
enabl
reliabl
fast
identif
respiratori
virus
purpos
cultur
influenza
viru
strain
mix
sampl
influenza
viru
hmpv
rsv
treat
develop
prepar
method
subsequ
obtain
peptid
subject
malditof
ms
lcmsm
analys
identif
respiratori
virus
base
peptid
sequenc
differ
abund
viral
protein
confirm
correct
identif
peptid
mass
spectrometri
amino
acid
sequenc
compar
correspond
dna
sequenc
obtain
sequenc
virus
final
determin
sensit
inhous
develop
method
titer
cultur
virus
determin
rrtpcr
clinic
influenza
strain
anonym
routin
diagnost
origin
collect
univers
medic
center
utrecht
umcu
collect
sampl
analysi
isol
viru
strain
approv
local
medic
ethic
committe
umcu
institut
review
board
irb
confirm
protocol
viral
strain
regard
patientown
materi
consequ
use
strain
restrict
dutch
law
law
medic
scientif
research
peopl
wmo
art
nasopharyng
swab
tracheal
aspir
collect
patient
hospit
respiratori
distress
symptom
ward
umcu
tabl
collect
sampl
cultur
immedi
either
cell
line
routin
check
cytopatholog
effect
cpe
format
sampl
exhibit
specif
cpe
cell
test
posit
respiratori
virus
realtim
pcr
harvest
store
c
next
eight
influenza
strain
design
two
influenza
strain
design
cultur
cell
presenc
emem
eagl
minim
essenti
medium
trypsin
c
tabl
addit
hmpv
design
rsv
type
design
cultur
cell
presenc
emem
trypsin
c
cell
presenc
dmem
dulbecco
modifi
eagl
medium
fb
fetal
bovin
serum
c
respect
tabl
subsequ
cultur
supernat
collect
cell
debri
remov
centrifug
g
min
aliquot
frozen
c
use
without
purif
step
determin
sensit
inhous
develop
sampl
prepar
method
titer
cultur
virus
determin
rrtpcr
use
standard
curv
standard
curv
develop
count
viru
particl
use
electron
microscopi
subsequ
perform
pcr
viral
rna
extract
pcr
perform
accord
previous
describ
protocol
tan
et
al
short
viral
genom
rna
isol
use
magnapur
lc
total
nucleic
acid
kit
accord
manufactur
guidelin
roch
diagnost
mannheim
germani
murin
encephalomyocard
viru
use
intern
control
revers
transcript
isol
viral
rna
perform
use
multiscrib
revers
transcriptas
kit
random
hexam
appli
biosystem
foster
citi
ca
usa
accord
manufactur
guidelin
pcr
primer
probe
design
basi
highli
conserv
genom
region
gene
influenza
n
gene
hmpv
rsv
primer
probe
use
type
viral
strain
primer
probe
use
list
tabl
cdna
sampl
analyz
l
reaction
mixtur
contain
l
cdna
taqman
univers
pcr
master
mix
appli
biosystem
abi
primer
fluorogen
probe
label
report
dye
fam
quencher
dye
tamra
amplif
detect
perform
abi
system
min
c
min
c
cycl
sec
c
min
c
sampl
assess
presenc
possibl
inhibitor
amplif
reaction
use
indic
intern
control
signal
rang
within
clearcut
interv
confirm
presenc
amino
acid
sequenc
accuraci
identifi
peptid
six
clinic
isol
sequenc
rsv
strain
access
number
sequenc
previous
tan
et
al
sequenc
purpos
hmpv
influenza
pcr
fragment
obtain
fraction
amplif
magnapur
lc
genom
rna
isol
use
superscript
iii
onestep
rtpcr
system
platinum
taq
high
fidel
kit
invitrogen
fast
thermal
cycler
abi
accord
manufactur
protocol
unlik
hmpv
rsv
influenza
viru
contain
segment
genom
consist
segment
segment
complet
amplifi
purifi
agaros
gel
prior
fraction
amplif
previous
describ
zhou
et
al
pcr
product
appli
agaros
gel
purifi
gel
gene
jet
gel
extract
kit
thermo
fisher
scientif
landsmeer
netherland
accord
manufactur
protocol
isol
fragment
use
wholegenom
sequenc
hmpv
influenza
strain
list
tabl
sequenc
accord
wholegenom
sequenc
protocol
describ
recent
use
convent
sanger
techniqu
tan
et
al
fragment
rang
nucleotid
sequenc
abi
dna
analyz
use
bigdy
termin
abi
result
sequenc
inform
assembl
hmpv
wholegenom
sequenc
align
correspond
refer
sequenc
genbank
http
wwwncbinlmnihgovgenbankindexhtml
use
seqman
softwar
dnastar
lasergen
similar
approach
follow
influenza
strain
tabl
provid
overview
primer
use
influenza
hmpv
rsv
sequenc
dna
amino
acid
sequenc
sequenc
strain
provid
supplementari
data
start
titer
viral
cultur
shown
tabl
start
titer
influenza
strain
rsv
appear
roughli
similar
copiesml
start
titer
hmpv
lower
tenfold
serial
dilut
strain
influenza
viru
rsv
hmpv
prepar
cymol
medium
copan
italia
brescia
itali
cymol
collect
transport
preserv
medium
cell
cytolog
analysi
virus
nucleic
acid
pcrbase
assay
luinstra
et
al
subsequ
l
tenfold
dilut
step
treat
accord
inhous
develop
sampl
pretreat
protocol
follow
l
aliquot
mix
l
stock
solut
rapigest
water
corpor
milford
ct
usa
incub
min
c
next
dldithiothreitol
dtt
sigmaaldrich
acetonitril
lcm
chromasolv
sigmaaldrich
ad
mm
final
concentr
respect
reduct
precipit
protein
perform
control
microwav
radiat
rapid
enzymat
digest
system
red
hudson
surfac
technolog
hst
inc
old
tappan
nj
usa
c
w
min
subsequ
carbamidomethyl
cystein
residu
execut
c
w
min
red
addit
iodoacetamid
iaa
sigmaaldrich
mm
final
concentr
next
proteinac
particl
precipit
g
min
supernat
discard
pellet
suspend
l
mm
ammonium
bicarbon
sigmaaldrich
contain
gml
modifi
tpcktreat
trypsin
bovin
pancrea
sigmaaldrich
digest
perform
min
red
c
w
termin
addit
trifluoroacet
acid
tfa
final
concentr
incub
c
min
rapigest
precipit
remov
centrifug
supernat
filter
microcon
filter
mwco
merck
millipor
ltd
co
cork
ireland
sampl
prepar
least
twice
analysi
mixtur
two
differ
viral
cultur
sampl
tenfold
dilut
influenza
mix
correspond
dilut
rsv
hmpv
cultur
sampl
respect
follow
exact
sampl
prepar
procedur
describ
sampl
prepar
least
twice
test
whether
human
protein
present
clinic
materi
interfer
develop
sampl
prepar
method
identif
lcmsm
reconstitut
throat
swab
includ
swab
rub
around
tonsil
volunt
wash
vortex
swab
cymol
medium
subsequ
socal
clinic
sampl
spike
dilut
cultur
influenza
viru
rsv
hmpv
sampl
prepar
lcmsm
analysi
procedur
describ
perform
reconstitut
clinic
sampl
test
sampl
prepar
least
twice
l
aliquot
sampl
desalt
c
ziptip
merck
millipor
ltd
peptid
elut
l
acetonitril
contain
mgml
acid
hcca
trifluoroacet
acid
tfa
elut
perform
directli
onto
maldi
target
mtp
polish
steel
bruker
dalton
gmbh
bremen
germani
droplet
airdri
spectra
record
reflector
mode
use
malditof
ms
instrument
autoflex
iii
bruker
spectrum
acquir
averag
laser
shot
laser
power
across
mass
rang
mz
follow
nois
reduct
instrument
mass
calibr
extern
peptid
standard
peptid
calibr
standard
bruker
spectra
analyz
flexanalysi
biotool
bruker
intern
calibr
perform
use
identifi
peptid
deriv
viral
nucleoprotein
trypsin
spectra
peak
list
gener
search
ncbi
viru
databas
databas
collect
virus
use
mascot
version
matrix
scienc
london
uk
mass
toler
ppm
perkin
et
al
koenig
et
al
carbamidomethyl
cystein
residu
oxid
methionin
includ
calcul
two
miss
cleavag
permit
mascot
score
system
use
determin
protein
expect
valu
correspond
number
match
expect
occur
chanc
alon
highest
expect
valu
consid
best
match
assay
perform
least
twice
separ
experi
peak
identifi
initi
nucleoprotein
np
peptid
influenza
subsequ
confirm
malditof
msm
msm
spectra
record
reflector
mode
use
lift
technolog
bruker
digest
analyz
lcmsm
use
nanoadv
lc
system
bruker
coupl
qtof
mass
spectromet
maxi
impact
bruker
l
aliquot
digest
sampl
inject
onto
magic
uhplc
nanotrap
column
id
mm
bruker
wash
load
solvent
h
formic
acid
min
flow
rate
lmin
follow
valv
switch
peptid
separ
magic
analyt
column
id
mm
c
bruker
constant
flow
nlmin
peptid
elut
gradient
h
formic
acid
b
ch
cn
min
follow
increas
b
min
optima
lcm
h
formic
acid
fisher
scientif
use
lcmsm
studi
nanolc
system
coupl
mass
spectromet
use
captivespray
bruker
ioniz
sourc
spray
voltag
set
kv
temperatur
heat
capillari
set
c
elut
peptid
analyz
use
datadepend
msm
mode
ten
abund
ion
charg
state
ms
spectrum
mz
select
datadepend
msm
analysi
collisioninduc
dissoci
use
nitrogen
collis
ga
msm
scan
acquir
mass
rang
mz
peak
list
gener
use
dataanalysi
softwar
version
bruker
list
export
mascot
gener
mgf
file
file
search
ncbi
databas
taxonomi
virus
mascot
search
algorithm
mascot
matrix
scienc
mass
toler
ppm
msm
toler
mmu
use
two
miss
cleavag
trypsin
allow
carbamidomethylcystein
select
fix
modif
oxid
methionin
variabl
modif
signific
protein
hit
least
two
uniqu
peptid
score
greater
select
ten
influenza
viru
strain
isol
hospit
patient
character
subtyp
level
eight
two
cultur
cell
result
viral
titer
rang
genom
copiesml
tabl
remov
cell
debri
tenfold
dilut
seri
viral
cultur
prepar
cymol
medium
dilut
treat
accord
inhous
develop
sampl
prepar
procedur
subsequ
peptid
subject
malditof
ms
analyz
mascot
softwar
two
independ
experi
test
influenza
strain
eight
two
correctli
identifi
base
recognit
peptid
deriv
nucleoprotein
tabl
fig
ten
influenza
strain
identifi
type
also
correctli
identifi
subtyp
tabl
entir
procedur
ie
dilut
seri
prepar
follow
treatment
accord
inhous
protocol
data
analysi
obtain
result
perform
within
h
ten
sampl
identif
limit
viral
strain
correctli
type
subtyp
appear
viral
genom
copi
total
sampl
volum
deposit
onto
maldi
plate
analysi
correspond
ct
valu
approxim
tabl
viral
titer
mass
peak
could
assign
high
signific
peptid
deriv
nucleoprotein
tabl
ident
approxim
half
peptid
peak
confirm
malditof
msm
data
shown
intens
remain
peptid
peak
assign
nucleoprotein
low
msm
analysi
genom
five
influenza
strain
name
sequenc
amino
acid
sequenc
identifi
peptid
found
encod
correspond
genom
sequenc
supplementari
data
genom
amino
acid
sequenc
sequenc
strain
protein
constitut
viral
proteom
peptid
identifi
occasion
data
shown
ms
spectra
also
contain
peak
abund
nonvir
protein
deriv
cell
lysat
actin
peptid
sn
list
peptid
identifi
test
viral
strain
titer
genom
copi
total
volum
sampl
deposit
onto
maldi
plate
analyz
nd
peptid
detect
ds
detect
sequenc
test
strain
anoth
peptid
due
miss
cleavag
trypsin
trypsin
autodigest
fragment
shown
unannot
peak
fig
sampl
prepar
procedur
follow
describ
peptid
subject
lcmsm
viru
identif
includ
sampl
prepar
analysi
achiev
less
h
ten
sampl
two
independ
experi
ten
influenza
strain
correctli
identifi
either
influenza
viru
identif
limit
genom
copi
total
sampl
volum
subject
lcmsm
analysi
correspond
ct
valu
approxim
tabl
viral
titer
influenza
virus
type
subtyp
base
identif
peptid
deriv
nucleoprotein
protein
indic
boldfac
tabl
nucleoproteinderiv
peptid
identifi
repeatedli
least
sampl
contain
viral
genom
copi
also
shown
tabl
addit
peptid
deriv
np
lcmsm
analysi
identifi
peptid
deriv
nonstructur
protein
ha
na
tabl
amino
acid
sequenc
coverag
protein
tenfold
dilut
viral
cultur
averag
valu
two
independ
experi
calcul
shown
tabl
similar
malditof
ms
result
identifi
amino
acid
sequenc
five
sequenc
strain
accord
respect
genom
sequenc
lcmsm
spectra
also
demonstr
protein
deriv
cell
lysat
cultur
addit
actin
lectin
histon
enolas
data
shown
moreov
peptid
detect
malditof
ms
also
identifi
lcmsm
tabl
tenfold
serial
dilut
strain
mix
correspond
dilut
factor
rsv
mixtur
result
approxim
ratio
strain
similarli
mixtur
b
tenfold
serial
dilut
strain
mix
correspond
dilut
factor
hmpv
although
start
titer
hmpv
time
lower
influenza
rsv
mixtur
treat
accord
inhous
develop
sampl
prepar
procedur
subject
lcmsm
subsequ
analyz
describ
sampl
contain
singl
viru
use
lcmsm
virus
mixtur
b
identifi
simultan
base
peptid
deriv
nucleoprotein
protein
influenza
strain
correctli
type
subtyp
sampl
dilut
contain
approxim
genom
copi
total
sampl
volum
subject
lcmsm
analysi
influenza
peptid
deriv
ha
na
protein
also
identifi
tabl
hmpv
rsv
strain
addit
nucleoproteinderiv
peptid
matrix
protein
matrix
protein
phosphoprotein
p
fusion
glycoprotein
f
also
identifi
tabl
identif
limit
rsv
strain
identifi
correctli
genom
copi
equival
total
sampl
volum
subject
lcmsm
analysi
correspond
ct
valu
approxim
tabl
hmpv
identif
limit
genom
copi
equival
total
sampl
volum
subject
lcmsm
analysi
correspond
ct
valu
approxim
tabl
identifi
peptid
sequenc
test
influenza
rsv
hmpv
strain
confirm
respect
genom
sequenc
data
supplementari
data
genom
amino
acid
sequenc
sequenc
strain
tenfold
serial
dilut
influenza
rsv
hmpv
spike
cymol
medium
contain
materi
throat
swab
reconstitut
clinic
sampl
treat
accord
inhous
develop
sampl
prepar
method
subject
lcmsm
analyz
describ
spike
respiratori
virus
identifi
influenza
rsv
sampl
tenfold
dilut
seri
test
influenza
strain
prepar
analyz
lcmsm
indic
total
genom
copi
analyz
influenza
viru
subject
lcmsm
b
amino
acid
sequenc
coverag
protein
determin
mascot
base
identifi
peptid
percentag
averag
combin
result
strain
protein
consid
significantli
identifi
mascot
score
minimum
three
peptid
score
identifi
np
nucleoprotein
matrix
protein
nonstructur
protein
ha
hemagglutinin
na
neuraminidas
c
identif
type
subtyp
base
highest
mascot
score
nucleoprotein
thu
given
subtyp
consid
indic
identif
data
extract
mascot
nd
peptid
sequenc
identifi
ds
identifi
sequenc
anoth
peptid
influenza
virus
genom
copi
type
subtyp
base
mainli
identif
peptid
deriv
nucleoprotein
shown
bold
influenza
hmpv
total
genom
copi
number
test
influenza
viru
rsv
total
sampl
volum
subject
lcmsm
analysi
b
identifi
viru
c
averag
sequenc
coverag
identifi
protein
calcul
two
independ
experi
protein
consid
identifi
mascot
score
minimum
three
peptid
score
identifi
protein
start
concentr
hmpv
time
lower
influenza
rsv
np
nucleoprotein
matrix
protein
nonstructur
protein
ha
hemagglutinin
na
neuraminidas
matrix
protein
f
fusion
glycoprotein
p
phosphoprotein
identif
viral
protein
reconstitut
clinic
materi
spike
virus
titer
averag
sequenc
coverag
identifi
protein
calcul
two
independ
experi
protein
consid
identifi
mascot
score
minimum
two
peptid
score
identifi
protein
np
nucleoprotein
matrix
protein
nonstructur
protein
ha
hemagglutinin
na
neuraminidas
matrix
protein
f
fusion
glycoprotein
p
phosphoprotein
c
posit
control
isol
viru
without
throat
swab
materi
one
two
test
sampl
peptid
detect
peptid
deriv
nucleoprotein
matrix
protein
nonstructur
protein
identifi
addit
rsv
sampl
also
peptid
deriv
matrix
protein
phosphoprotein
identifi
one
two
test
hmpv
sampl
two
peptid
deriv
phosphoprotein
identifi
tabl
identif
limit
influenza
detect
genom
copi
total
sampl
volum
subject
lcmsm
influenza
rsv
approxim
genom
copi
hmpv
genom
copi
accur
rapid
identif
influenza
respiratori
virus
import
combat
outbreak
epidem
detect
newli
emerg
virus
initi
prophylaxi
earli
therapi
antigendetect
rrtpcr
test
use
frequent
detect
virus
acut
phase
pcrbase
method
yield
result
within
h
high
sensit
specif
center
diseas
control
prevent
guidanc
clinician
use
rrtpcr
molecular
assay
diagnosi
influenza
viru
infect
wherea
rapid
antigendetect
test
even
yield
result
within
min
howev
method
featur
drawback
targetdirect
potenti
miss
nonselect
emerg
pathogen
virus
cover
pcr
primer
set
antibodi
use
antigendetect
assay
instanc
shown
new
type
human
papillomaviru
hpv
detect
broad
hpvprimer
pcr
system
johansson
et
al
newli
emerg
mutat
conserv
region
prevent
rrtpcr
detect
influenza
clinic
specimen
binnick
et
al
yang
et
al
ii
multipl
test
differ
pcr
pcr
follow
sequenc
need
sub
type
detect
mix
infect
iii
sensit
rapid
antigendetect
test
low
commonli
use
rapid
influenza
diagnost
test
ridt
although
fast
lack
accuraci
sensit
result
high
percentag
falseneg
result
beck
et
al
theoret
mass
spectrometrybas
system
could
overcom
drawback
alreadi
investig
identif
respiratori
virus
howev
use
sampl
prepar
method
labori
timeconsum
mass
spectrometri
identif
method
clinic
potenti
therefor
studi
rapid
gener
robust
sampl
prepar
method
mass
spectrometrybas
viru
identif
develop
subsequ
sensit
combin
procedur
sampl
prepar
mass
spectrometri
analysi
determin
tenfold
serial
dilut
ten
cultur
influenza
strain
two
differ
subtyp
mix
sampl
influenza
viru
either
hmpv
rsv
reconstitut
clinic
sampl
treat
inhous
develop
sampl
prepar
method
without
prior
purif
labori
procedur
apart
standard
remov
cell
debri
subsequ
peptid
subject
malditof
ms
lcmsm
identifi
use
webbas
mascot
search
algorithm
confirm
correct
identif
amino
acid
sequenc
compar
correspond
dna
sequenc
obtain
sequenc
influenza
strain
success
identifi
subtyp
level
mass
spectrometri
system
identif
virus
achiev
within
h
malditof
ms
within
h
lcmsm
exclud
time
necessari
cultur
virus
sensit
malditof
ms
lower
detect
limit
tabl
compar
lcmsm
detect
limit
tabl
latter
correspond
ct
valu
earlier
studi
alreadi
shown
possibl
identifi
highli
pure
andor
concentr
influenza
virus
malditof
ms
maldifticr
ms
lcmsm
schwahn
et
al
schwahn
et
al
b
chou
et
al
jang
et
al
nguyen
downard
fernand
downard
li
et
al
howev
sampl
prepar
method
use
timeconsum
h
labori
therefor
suitabl
rapid
applic
studi
nucleoproteinderiv
peptid
found
among
identifi
viral
peptid
detect
schwahn
et
al
b
li
et
al
indic
inhous
develop
sampl
prepar
method
compar
result
could
achiev
much
shorter
time
furthermor
develop
sampl
prepar
method
prior
purif
extend
concentr
cultur
virus
exampl
appli
ultracentrifug
requir
identif
viral
protein
presenc
viral
nonvir
protein
sampl
prepar
time
significantli
reduc
approxim
h
introduct
red
rapid
reduct
alkyl
precipit
trypsin
digest
tenfold
serial
dilut
cultur
virus
prepar
cymol
collect
transport
preserv
medium
known
compat
multipl
diagnost
platform
includ
cytolog
molecular
diagnost
luinstra
et
al
suspend
virus
cymol
significantli
approxim
improv
identif
limit
compar
test
solut
ammonium
bicarbon
nte
buffer
mm
nacl
mm
trishcl
ph
mm
edta
pb
phosphat
buffer
salin
univers
transport
medium
utmrt
data
shown
besid
monocultur
influenza
strain
mix
sampl
influenza
viru
either
hmpv
rsv
subject
malditof
ms
lcmsm
virus
identifi
simultan
specif
lcmsm
tabl
detect
limit
influenza
rsv
genom
copi
hmpv
identif
possibl
malditof
ms
due
low
sensit
addit
monocultur
mix
sampl
throat
swab
spike
influenza
hmpv
rsv
subject
lcmsm
spike
virus
identifi
detect
limit
genom
copi
influenza
influenza
rsv
hmpv
respect
result
demonstr
lcmsm
abl
identifi
monocultur
virus
also
discrimin
two
virus
sampl
identifi
viru
sampl
contain
human
protein
origin
throat
swab
sensit
lcmsm
appear
lower
mix
sampl
reconstitut
sampl
test
viral
load
clinic
sampl
vari
depend
type
respiratori
materi
subtyp
viru
sever
phase
infect
host
factor
immun
gener
viral
load
fall
within
rang
genom
copiesml
ngaosuwankul
et
al
lee
et
al
addit
recent
paneuropean
survey
nuttal
et
al
averag
ct
valu
influenza
viru
rsv
hmpv
detect
patient
respect
coenjaert
fej
person
commun
therefor
ultim
identif
limit
mass
spectrometri
method
reach
genom
copiesml
direct
clinic
applic
sensit
develop
sampl
prepar
method
combin
lcmsm
lower
therefor
good
enough
direct
applic
virolog
diagnost
detect
virus
clinic
sampl
viral
cultur
need
sampl
prepar
analyz
cultur
requir
viabl
viru
recov
success
grown
applic
virolog
diagnost
sensit
increas
develop
techniqu
enabl
fast
effici
viru
concentr
purif
respiratori
sampl
furthermor
mass
spectrometri
system
improv
increas
sensit
meanwhil
keep
drawback
mind
inhous
develop
sampl
prepar
method
combin
lcmsm
could
experiment
use
patient
suspicion
respiratori
infect
routin
diagnost
neg
identif
influenza
strain
rsv
hmpv
base
detect
peptid
deriv
differ
protein
identifi
peptid
found
encod
correspond
genom
sequenc
malditof
ms
lcmsm
detect
nucleoproteinderiv
peptid
addit
lcmsmsidentifi
peptid
deriv
viral
protein
name
ha
na
protein
influenza
virus
p
f
protein
rsv
hmpv
identif
peptid
differ
protein
accomplish
identif
also
potenti
deliv
inform
virul
resist
antivir
medic
andor
transmiss
effici
instanc
amino
acid
substitut
nucleoprotein
shown
enhanc
humantohuman
transmiss
zhou
et
al
interestingli
one
identifi
nucleoproteinderiv
peptid
ie
qanngedataglthimiwhsnlndatyqr
contain
substitut
peptid
found
test
influenza
strain
tabl
suggest
strain
might
exhibit
increas
humantohuman
transmiss
effici
conclus
mass
spectrometri
system
investig
identif
highli
pure
andor
concentr
influenza
virus
howev
use
sampl
prepar
method
labori
timeconsum
develop
sampl
prepar
method
combin
lcmsm
allow
rapid
reliabl
identif
cultur
respiratori
virus
virus
spike
throat
swab
introduc
lcmsm
base
identif
method
virolog
diagnost
sensit
must
improv
clinic
sampl
test
combin
improv
mass
spectrometri
techniqu
andor
clinic
sampl
prepar
method
allow
direct
identif
virus
clinic
sampl
import
new
diagnost
tool
clinic
virolog
author
declar
compet
interest
